Art Sedrakyan is an Honorary Professor at the Department of Health Services Research & Policy in the Research School of Population Health, the Australian National University. He is a trained CT surgeon and a graduate of Johns Hopkins University in USA with Ph.D in Health Policy and Management.
He is a Professor at Weill Cornell Medicine and leads number of International Efforts including the US Food and Drug Administration’s (FDA) Medical Device Epidemiology (MDEpiNet) Science and Infrastructure Center Prof Sedrakyan is the initiator (with FDA) and principal investigator of the FDA’s International Consortium of Orthopedic Registries (ICOR, www.icor-initiative.org), International Consortium of Cardiac Registries (ICCR) and International Consortium of Vascular Registries (ICVR, www.icvr-initiative.org). These national and international initiatives aim to advance the infrastructure for comparative effectiveness, regulatory science and surveillance for interventions and medical devices. The efforts are based on distributed (federated) models and revolutionize the health services research and population based approach in the interventional medicine.
He previously worked at US Food and Drug Administration (FDA) and had held appointments as senior service officer/senior adviser at the Agency for Healthcare Research and Quality (AHRQ) from 2005 to 2009. He was a lead adviser on interventions including surgery), implantable devices and cardiovascular and orthopedic content areas. He was one of initiators of the Effective Healthcare Cardiovascular Consortium and supervised centers for Education and Research in Therapeutics (CERTS); Cardiovascular CERT and orthopedic Device CERT.
Prior to his US government appointments he worked in the United Kingdom and has registry research, evidence synthesis and teaching experience from Royal College of Surgeons (RCS) of England and London School of Hygiene (LSHTM), where he served as a faculty and was Senior Adviser for National Collaborating Center for Acute Care (part of UK National Institute of Clinical Excellence (NICE)).
He serves as ranking member and was previously the Vice-Chair of US Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). He is serving on MEDCAC since June 1, 2010. http://www.cms.gov/Regulations-and- Guidance/Guidance/FACA/MEDCAC.html. Dr. Sedrakyan is also the Vice-Chair of the IDEAL initiative that is the main international organization dealing with technology innovation and its evaluation with special interest/leadership area in devices (www.ideal-collaboration.net).
Starting January 9, 2017 Professor Sedrakyan is a specialist advisor to Therapeutic Goods Administration (TGA) in Australia.
He has over 150 publications and is frequently publishing in BMJ, JAMA, Lancet and high impact surgical journals. PubMed link: https://www.ncbi.nlm.nih.gov/pubmed/?term=sedrakyan+a